Biosimilar Adoption Policy Proves Successful After 8 Years in a UK Tertiary Hospital
January 28th 2024
By Skylar Jeremias
ArticleDuring a 6-year follow-up period, a UK tertiary hospital observed greater biosimilar adoption than the English average after it implemented a new policy that prioritizes best-value biologics, including biosimilars, for new-start patients and those already treated with originators.